AEZS

AEterna Zentaris Inc. Press Releases

$0.533
*  
0.003
0.57%
Get AEZS Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading AEZS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Aeterna Zentaris Inc. (AEZS) to Contact the Firm
11/21/2014 8:20:00 PM - Market Wire


Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer
11/20/2014 7:30:00 AM - PR Newswire


Notice of Filing of Securities Fraud Class Action Against Aeterna Zentaris Inc. by Kantrowitz, Goldhamer & Graifman, P.C.
11/17/2014 4:45:00 PM - Market Wire


Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter & Twersky, LLP
11/17/2014 10:33:00 AM - Business Wire


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aeterna Zentaris, Inc. - AEZS
11/14/2014 1:46:00 PM - PR Newswire
▼-4.82 % Price Change since this news event. The Volume Ratio is 0.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zentaris Inc. (AEZS) To Contact The Firm
11/11/2014 5:15:00 PM - PR Newswire
▼-11.17 % Price Change since this news event. The Volume Ratio is 0.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Issues Complete Response Letter for Aeterna Zentaris'' Macrilen™ NDA in Adult Growth Hormone Deficiency
11/6/2014 7:00:00 AM - PR Newswire
▼-58.68 % Price Change since this news event. The Volume Ratio is 6.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results
11/4/2014 4:30:00 PM - PR Newswire
▼-50.19 % Price Change since this news event. The Volume Ratio is 3.58.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014
10/28/2014 7:30:00 AM - PR Newswire
▼-56.31 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel®
10/27/2014 7:30:00 AM - PR Newswire
▼-54.83 % Price Change since this news event. The Volume Ratio is 20.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and Corporate Secretary
10/7/2014 7:30:00 AM - PR Newswire


Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York
9/2/2014 4:15:00 PM - PR Newswire